The Boston-based health system conducted a study to evaluate how the remote program could help manage patients’ blood pressure and cholesterol levels, according to a Nov. 9 press release from Mass General. The results were published Nov. 9 in JAMA Cardiology.
The study enrolled 10,803 participants — 3,658 patients with hypertension, 8,103 patients with high cholesterol and 958 patients with both.
The researchers found that the program was able to improve health outcomes, provide consistent care and reach underserved populations. The program also was able to reduce high blood pressure and improvements in cholesterol levels across a large and diverse group of people.
The researchers believe the success of this program shows it could be rolled out more widely and has the potential to particularly help those patients for whom in-person visits are difficult.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.